ANDA 40397, held by Epic Pharma LLC. Carisoprodol.
As of Nov 16, 2026, ANDA 40397 (Carisoprodol), held by Epic Pharma LLC, was first approved by FDA on Sep 21, 2000, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 21, 2000 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Carisoprodol350MG · tablet;oral | Carisoprodol | Discontinued |
| Apr 22, 2020 | Supplement 8Labeling · Standard review | Approved | None posted |
| Apr 22, 2020 | Supplement 7Labeling · Standard review | Approved | None posted |
| Jul 14, 2011 | Supplement 6Labeling | Approved | None posted |
| Mar 19, 2009 | Supplement 5Labeling | Approved | None posted |
| Jan 29, 2009 | Supplement 2Labeling | Approved | None posted |
| Jan 25, 2007 | Supplement 1Labeling | Approved | None posted |
| Sep 21, 2000 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters